Glioma
6 competing products in clinical development for Glioma.
Pipeline by Phase
Phase 13
Phase 23
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib + Bevacizumab | Eisai | Phase 2 | Completed | 35 |
| DS-1001b | Daiichi Sankyo | Phase 1 | Active | 33 |
| Temozolomide and Bevacizumab | Eisai | Phase 2 | UNKNOWN | 31 |
| Temozolomide | Eisai | Phase 2 | UNKNOWN | 31 |
| LY2157299 + Lomustine | Eli Lilly | Phase 1 | Completed | 29 |
| Temozolomide | Novocure | Phase 1 | Terminated | 15 |